Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
36.03
+0.76 (2.15%)
May 16, 2025, 12:25 PM - Market open

Sarepta Therapeutics Market Cap

Sarepta Therapeutics has a market cap or net worth of $3.54 billion as of May 16, 2025. Its market cap has decreased by -70.76% in one year.

Market Cap
3.54B
Enterprise Value
4.33B
1-Year Change
-70.76%
Ranking
Category
Stock Price
$35.97

Market Cap Chart

Created with Highcharts 11.4.8Range1 Month1M6 Months6MYear to DateYTD1 Year1Y3 Years3Y5 Years5Y10 Years10YFull HistoryMax1 Dec 199814 May 2025Max ▾200020022004200620082010201220142016201820202022202402.50B5.00B7.50B10.00B12.50B15.00B3.51B

Since December 1, 1998, Sarepta Therapeutics's market cap has increased from $58.40M to $3.54B, an increase of 5,953.12%. That is a compound annual growth rate of 16.77%.

History

DateMarket Cap% Change
May 14, 20253.51B-69.76%
Dec 31, 202411.61B28.75%
Dec 29, 20239.02B-20.70%
Dec 30, 202211.37B45.06%
Dec 31, 20217.84B-41.72%
Dec 31, 202013.45B39.87%
Dec 31, 20199.62B31.90%
Dec 31, 20187.29B102.79%
Dec 29, 20173.60B140.16%
Dec 30, 20161.50B-14.27%
Dec 31, 20151.75B192.17%
Dec 31, 2014597.80M-21.92%
Dec 31, 2013765.60M16.58%
Dec 31, 2012656.70M549.55%
Dec 30, 2011101.10M-57.54%
Dec 31, 2010238.10M47.70%
Dec 31, 2009161.20M244.44%
Dec 31, 200846.80M-38.26%
Dec 31, 200775.80M-54.99%
Dec 29, 2006168.40M10.50%
Dec 30, 2005152.40M79.51%
Dec 31, 200484.90M-33.15%
Dec 31, 2003127.00M-3.93%
Dec 31, 2002132.20M-47.73%
Dec 31, 2001252.90M148.18%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 651.53B
Johnson & Johnson 353.07B
AbbVie 318.57B
Novo Nordisk 291.59B
UnitedHealth Group 286.01B
Abbott Laboratories 224.94B
Novartis AG 209.81B
AstraZeneca 209.59B
Market Cap Rankings